A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study

Bradley J. Monk, Mark F. Brady, Carol Aghajanian, Heather A. Lankes, Tina Rizack, Joseph W. Leach, J.M. Fowler, Robert V. Higgins, P. Hanjani, Mark A. Morgan,

Annals of Oncology · 2017 · 93 citations · 19 references

DOIFull text

Open access

Concepts

References

19